Skip to Content

Influenza virus vaccine, h5n1 Disease Interactions

There are 3 disease interactions with influenza virus vaccine, h5n1:


Influenza Virus Vaccine H5N1 (Includes Influenza virus vaccine, h5n1) ↔ Guillain-Barre Syndrome (Gbs)

Severe Potential Hazard, Moderate plausibility

Applies to: Guillain-Barre Syndrome

Careful consideration of the potential risks and benefits should be given before deciding to give the influenza virus vaccine H5N1 to any patient who developed GBS within 6 weeks of receipt of a prior influenza vaccine.


Influenza Virus Vaccine H5N1 (Includes Influenza virus vaccine, h5n1) ↔ Hemophilia

Moderate Potential Hazard, Moderate plausibility

Applies to: Bleeding Associated with Coagulation Defect

As with other intramuscular injections, this vaccine should be given with caution in individuals with bleeding disorders, such as hemophilia or on anticoagulation therapy, to avoid the risk of hematoma following the injection.


Influenza Virus Vaccine H5N1 (Includes Influenza virus vaccine, h5n1) ↔ Immunodeficiency

Moderate Potential Hazard, Moderate plausibility

Applies to: Immunodeficiency

If Influenza Virus Vaccine, H5N1, is administered to immunocompromised patients, including individuals receiving immunosuppressive therapy, the expected immune response may not be obtained.

influenza virus vaccine, h5n1 drug Interactions

There are 189 drug interactions with influenza virus vaccine, h5n1

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2018 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.